Nintedanib Plus Docetaxel Improves PFS and OS for Patients with Stage IIIB/IV or Recurrent Lung Adenocarcinoma

Article Information

DOI 
http://dx.doi.org/10.1177/155989771306008
Published By 
SAGE Publications
Print ISSN 
1559-8977
Online ISSN 
2155-756X
Copyright & Usage 
© 2013 MD Conference Express®

Author Information

  1. Maria Vinall
  1. Martin Reck, MD, PhD
    1. Lungen Clinic Grosshansdorf, Grosshansdorf, Germany
View Full Text

Article usage

AbstractFullPDF
Apr 2015500
May 2015200
Jun 2015900
Jul 2015400
Aug 2015700
Sep 2015200
Oct 2015243
Total3143

Note: Article usage statistics are calculated and reported monthly.

Cited By...

  • No citing articles found.
Back to top

Tools

View Full Page PDF
Citation Tools
Email
Nintedanib Plus Docetaxel Improves PFS and OS for Patients with Stage IIIB/IV or Recurrent Lung Adenocarcinoma
Permalink: Copy
Linkedin Share Button del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo StumbleUpon logo

Table of contents

Cited By...

  • No citing articles found.

Keywords

Oncology Clinical Trials
Cancer
Respiratory Cancers
Oncology Clinical Trials
Cancer
Oncology
Respiratory Cancers